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Since the early part of the last decade, the prostate cancer literature has been rife with articles 
purporting the utility of minimally invasive surgery for the performance of radical prostatectomy. There 
have been opponents citing lack of tactile feedback, an increased incidence of the need for salvage 
therapy and an increased complication rate, especially in the early literature comparing open and 
laparoscopic techniques. Some even argued that there is no difference in terms of length of hospital stay 
and return to normal activity, a finding which may be achievable at some centers but one which seems 
intuitively unlikely when broadly applied considering the findings for any other type of minimally 
invasive procedure. Some would also suggest that the additional costs are not justified. Conversely, the 
advocates would argue that the better visualization in a less bloody field has resulted in the exact opposite 
findings with decreased complication rates, decreased use of salvage therapy and decreased hospital stay. 
Ultimately these questions can only be definitively answered with a randomized clinical trial 
comparing open and laparoscopic techniques, but the likelihood of successful completion of such is near 
nil. The predominance of robotic laparoscopic prostatectomies being performed in the United States and 
probably worldwide would indicate that patients have made up their minds on this issue with that being 
that whenever feasible, prostatectomies in the future will be performed with a robotic laparoscopic 
technique. 
Nevertheless, demonstrations of oncologic equivalence and comparable quality of life outcomes 
are most important. In the absence of a randomized clinical trial, we are dependent upon single institution 
reports and administrative databases to gather these data with their acknowledged limitations. Single 
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institution reports are basically noninformative about this issue other than what is achievable at that 
institution. In this issue of The Journal Pearce et al (page 76) use the National Cancer Database of the 
American Cancer Society and American College of Surgeons to answer some of these questions.1 
Using 2 different statistical techniques to match the open prostatectomy and robotic 
prostatectomy groups, they found that robotic prostatectomy results in improvement in the only oncologic 
outcome that a surgical technique can meaningfully affect, that of positive surgical margins. Stage for 
stage, robotic prostatectomy was better. While these authors also found that patients treated with robotic 
prostatectomy needed adjuvant radiation therapy less often, this finding depends not only on complete 
surgical excision but also on where the surgery is performed and local practice patterns in the use of 
adjuvant radiation therapy. 
There are certainly potential weaknesses to this study such as the potential that robotic surgery 
was more often performed at high volume centers compared to open prostatectomy, which might be the 
reason for the superior results with the robotic technique. It really doesn’t matter. The conclusion that 
robotic prostatectomy as currently performed in the United States has superior oncologic results to open 
prostatectomy as it is currently being done is inescapable, despite the reason for that difference. 
The issue of which approach leads to better quality of life outcomes has been inconclusive up to 
this point and, certainly, excellent outcomes can be achieved with either approach depending on the skill 
and experience of the surgeon. Studies using administrative databases based on surgical coding have 
suggested that incontinence is more often coded for and subsequent surgical procedures for incontinence 
are performed more frequently in patients undergoing robotic prostatectomy. Most of these studies are 
old, have multiple limitations, were conducted during the early adoption of robotic prostatectomy and 
have questionable validity. 
O’Neil et al examined the morbidity of open and robotic prostatectomy based on validated 
questions in patients in the CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation) and 
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PCOS (Prostate Cancer Outcomes Study) clinical trials.2 The majority of the patients treated with robotic 
prostatectomy in this report were from the CEASAR trial and had surgery in 2011 to 2012. In this study 
robotic prostatectomy was associated with statistically superior urinary control at 6 months and 
statistically significant improvement in sexual function at both 6 months and 12 months. It is likely that in 
this study, as in that of Pearce et al,1 robotic prostatectomy was performed by higher volume surgeons. 
Leow et al examined the morbidity of open vs robotic prostatectomy in an all-payer database, the 
Premier hospital database, and found that 90-day complication rates were 32% less likely with robotic 
prostatectomy and transfusions were 66% less likely.3 They were also able to shed light on the issue of 
additional expense. These authors found that while robotic prostatectomy was associated with an 
additional expense of $4,528 for the 90-day period, the highest volume surgeons had an additional 
expense of only $1,990. In their view the small incremental cost, especially in the hands of high volume 
surgeons, is justified by the reduction in morbidity for the patient. 
From my standpoint, as someone who has substantial surgical experience with both techniques, 
robotic prostatectomy has superior or at least equal oncologic efficacy and complication rates compared 
to open prostatectomy and in 2016 any small incremental expense justifies its use. I believe the most 
current literature supports that view and this debate should finally be put to rest. 
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